期刊文献+

动机性访谈对促进非瓣膜性房颤患者服用华法令的依从性的调查 被引量:2

Investigation of motivational interviewing on promotion of warfarin compliance in patients with non-valvular atrial fibrillation
下载PDF
导出
摘要 目的通过对非瓣膜性房颤患者实施动机性访谈(MI),评价患者服用华法令的依从性。方法将80例老年房颤患者随机分为对照组和干预组,各40例。对照组给予常规护理,干预组在此基础上给予MI干预。随访6个月,对干预前、出院时、出院后1个月、3个月6个月时进行问卷调查法分别评估MI对非瓣膜性房颤患者服用华法令的依从性的效果。结果与对照组比较,干预组经MI干预后出院时、1个月、3个月及6个月患者服药依从意愿和信心显著提高(P<0.05)。结论 MI可促进非瓣膜性房颤患者服用华法令的依从性。 Objective To explore effect of motivational interviewing (MI) on promotion of warfarin compliance in patients with non-valvular atrial fibrillation. Methods Eighty patients with at- rial fibrillation were randomly divided into intervention group and control group, 40 cases in each group. The control group was given routine nursing, while the intervention group was given MI inter- vention on the basis of the control group. After 6 months of follow-up, the effects of MI intervention on warfarin compliance were evaluated by questionnaire at the time points of before intervention, hospital discharge and 1, 3, 6 months after hospital discharge. Results Compared with the control group, the willing and confidence of drug administration compliance at the time points of hospital discharge and 1, 3, 6 months after hospital discharge were significantly better in the intervention group (P 〈 0.05). Conclusion MI can promote the compliance of warfarin in patients with non-valvular atrial fibrillation.
出处 《中西医结合护理(中英文)》 2016年第3期38-40,43,共4页 Journal of Clinical Nursing in Practice
关键词 心房颤动 非瓣膜性房颤 华法令 动机性访谈 依从性 atrial fibrillation non-valvular atrial fibrillation warfarin motivational inter- viewing compliance
  • 相关文献

参考文献3

二级参考文献62

  • 1骆宏,许百华.动机性访谈:一种以咨客为中心的行为改变咨询技术[J].应用心理学,2005,11(1):85-89. 被引量:49
  • 2[9]Poli D,Antonucei E,Cecchi E,et al.Culprit factors for the failure of well-conducted warfarin therapy to prevent ischemic events in patients with atrial fibrillation:the role of homocysteine[J].Stroke,2005,36(10):2159-2163.
  • 3[10]Fang MC,Singer DE,Chang Y,et al.Gender differences in the risk of ischemie stroke and peripheral embolism inatrial fibrillation:the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study[J].Circulation,2005,112(12):1687-1691.
  • 4[11]Lip GY,Hart RG,Conway DS.Antithrombotic therapy for atrial fibrillation[J].BMJ,2002,325 (7371):1022-1025.
  • 5[12]Fuster V,Ryden LE,Cannom DS,et al.ACC/AHA/ESC2006 guidelines for the management of patients with atrial fibrillation-executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation)[J].J Am Coil Cardiol,2006,48(4):854906.
  • 6[13]Go AS,Fang MC,Singer DE.Antithrombotic therapy for stroke prevention in atrial fibrillation[J].Prog Cardiovasc Dis,2005,48(2):108-124.
  • 7[14]Economides Munoz C,Singh BN.Antithrombotic therapies for stroke prevention in atrial fibrillation[J].Minerva Cardioangiol,2004,52 (2):125-139.
  • 8[15]O'Donnell M,Weitz JI.Emerging therapies for stroke prevention in atrial fibrillation[J].Eur Heart J,2005,7(Suppl C):C19-C27.
  • 9[16]Ostermayer SH,Reisman M,Kramer PH,et al.Percutaneous left atrial appendage transcatheter occlusion(PLAATO system)to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation:results from the international multi-center feasibility trials[J].J Am CoilCardiol,2005,46(1):9-14.
  • 10[17]Sievert H,Lesh MD,Trepels T,et al.Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation:early clinical experience[J].Circulation,2002,105(16):1887-1889.

共引文献82

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部